Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.19
-0.02-1.65%
At close: -
$1.18
-0.00570-0.48%
After Hours: Jun 20, 6:36 PM EDT
Comments
Loading...
Fate Therapeutics (FATE) Forecast
NewsEarningsFate Therapeutics (FATE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Fate Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:FATE | Benzinga
Explore Fate Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FATE.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Fate Therapeutics (FATE) stock?
You can purchase shares of Fate Therapeutics (NASDAQ:FATE) through any online brokerage.
Who are Fate Therapeutics (FATE) competitors?
There are no as such competitors for Fate Therapeutics.
What is the forecast, or price target, for Fate Therapeutics (FATE) stock?
Fate Therapeutics has a consensus price target of $6.21.
What is the current price for Fate Therapeutics (FATE)?
The stock price for Fate Therapeutics (NASDAQ: FATE) is $1.1843 last updated June 20, 2025 at 6:36 PM EDT.
Does Fate Therapeutics (FATE) pay a dividend?
There are no upcoming dividends for Fate Therapeutics.
When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?
Fate Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Fate Therapeutics (FATE) going to split?
There is no upcoming split for Fate Therapeutics.
What sector and industry does Fate Therapeutics (FATE) operate in?
Fate Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
